Alexander J. Erickson

Alexander J. Erickson

Auto-generated profile, based on publicly available information

Alexander J. Erickson

Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
JMJennifer L. Martin
Jennifer L. Martin
GCGwendolyn C. Carlson
Gwendolyn C. Carlson
MKMonica R. Kelly
Monica R. Kelly
YSYeonsu Song
Yeonsu Song
MMMichael N. Mitchell
Michael N. Mitchell
EYElizabeth M. Yano
Elizabeth M. Yano
This randomized comparative effectiveness trial evaluated a novel insomnia treatment using acceptance and commitment therapy (ACT) among women veterans. Participants received either the acceptance and the behavioral changes to treat insomnia (ABC-I) or cognitive behavioral therapy for insomnia (CBT-I). The primary objectives were to determine whether ABC-I was noninferior to CBT-I in improving sleep and to test whether ABC-I resulted in higher treatment completion and adherence versus CBT-I. One hundred forty-nine women veterans with insomnia disorder (Mage = 48.0 years) received ABC-I or CBT-I. The main sleep outcomes were Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and sleep efficiency (SE) by actigraphy (objective) and sleep diary (subjective). Measures were collected at baseline, immediate posttreatment, and 3-month posttreatment follow-up. Treatment completion and adherence were assessed during the interventions. Both interventions improved all sleep outcomes from baseline to immediate posttreatment and 3-month posttreatment follow-up. At immediate posttreatment, ABC-I was statically noninferior for sleep diary SE and objective SE, but noninferiority was not statistically confirmed for ISI or PSQI total scores. At 3-month posttreatment follow-up, ABC-I was noninferior for all four of the key outcome variables. There was not a statistically significant difference between the number of participants who discontinued CBT-I (11%) versus ABC-I (18%; p = .248) before completing treatment. ABC-I was superior to CBT-I for some adherence metrics. Overall, ABC-I was similar in effectiveness compared to CBT-I for the treatment of insomnia and may improve adherence to some behavioral elements of treatment. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

18 June 2024 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
AEAlexander J. Erickson
Alexander J. Erickson
JRJuan Carlos Rodriguez
Juan Carlos Rodriguez
SRScott G. Ravyts
Scott G. Ravyts
JDJoseph M. Dzierzewski
Joseph M. Dzierzewski
CFConstance H. Fung
Constance H. Fung
CACathy A. Alessi
Cathy A. Alessi

31 July 2024 in Journal of LGBTQ Issues in Counseling
Verified
Journal Article
Closed access
MSMegan Speciale
Megan Speciale
MLMargaret Lamar
Margaret Lamar
AEAlexander J. Erickson
Alexander J. Erickson

21 January 2024 in Journal of Sleep Research
Verified
Journal Article
Closed access
AEAlexander J. Erickson
Alexander J. Erickson
SRScott G. Ravyts
Scott G. Ravyts
JDJoseph M. Dzierzewski
Joseph M. Dzierzewski
GCGwendolyn C. Carlson
Gwendolyn C. Carlson
MKMonica R. Kelly
Monica R. Kelly
JMJennifer L. Martin
Jennifer L. Martin

7 October 2026 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
PDF file
GCGwendolyn C. Carlson
Gwendolyn C. Carlson
GGGiselle Gomez
Giselle Gomez
KCKatie J. Carlson
Katie J. Carlson
CMChase H. G. MacCabe
Chase H. G. MacCabe
AGAlaina I. Gold
Alaina I. Gold
JMJennifer L. Martin
Jennifer L. Martin

10 January 2026 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
JHJennifer G. Hurtado
Jennifer G. Hurtado
AEAlexander J. Erickson
Alexander J. Erickson
MMMichael N. Mitchell
Michael N. Mitchell
JMJennifer L. Martin
Jennifer L. Martin
CACathy A. Alessi
Cathy A. Alessi
CFConstance H. Fung
Constance H. Fung
Background: Older adults with chronic insomnia often use benzodiazepine receptor agonists (BZRAs) despite known associated risks and non‐pharmacological alternatives such as cognitive behavioral therapy for insomnia (CBTI). CBTI reduces insomnia severity and could potentially improve other outcomes such as the impact of pain on daily activities, even when BZRAs are deprescribed. Yet concerns that deprescribing may worsen pain (which is often comorbid with insomnia) can be a barrier to engagement in BZRA deprescribing. This study examined changes in pain outcomes associated with deprescribing BZRAs in the context of concurrent CBTI. Methods: Secondary data analysis was conducted using data from a randomized clinical trial that successfully decreased BZRA use in older adults. Participants ( n = 188), who were largely older (68% ≥ 65 years, 55 ≤ range ≤ 91) and male (65%), completed CBTI concurrently with a deprescribing intervention (blinded encapsulated BZRA taper or open pill cutter taper). Participants completed the Brief Pain Inventory (BPI) at baseline, one week posttreatment (1 WK), and at a six‐month (6 M) follow‐up. Analyses included mixed effects models among all participants and a subset aged 65+ as well as comparison of model results to minimal clinically important difference (MCID) thresholds. Results: Mixed effects models demonstrated that pain severity did not change significantly over time, broadly or in participants aged ≥ 65 years. Significant reductions in pain interference in day‐to‐day living at 1 WK were observed broadly, although these reductions did not meet the MCID threshold and were no longer significant at 6 M follow‐up. Conclusions: Combined BZRA deprescribing and CBTI did not meaningfully worsen pain in older adults. These results highlight the opportunity for using a combination of CBTI and deprescribing methods in patients with insomnia and comorbid pain, as well as a need for additional interventions to specifically address pain in older adults with chronic insomnia.